» Articles » PMID: 33831187

Causes, Pattern, Predictors, and Prognostic Implications of New Hospitalizations After Transcatheter Aortic Valve Implantation: a Long-term Nationwide Observational Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The aim of this study was to investigate the pattern, causes, and predictors of all new hospitalizations in patients who underwent transcatheter aortic valve implantation (TAVI).

Methods And Results: The nationwide Swedish TAVI registry was merged with other mandatory healthcare registries, which enabled the analysis of all TAVI procedures, new hospital admissions, and death between the years 2008 and 2017. A total of 2821 patients underwent TAVI with a mean of 2.5 hospitalizations during a mean follow-up of 2.2 years. Hospitalizations were associated with worse prognosis. Heart failure (HF) was the most common cause of hospitalization with 19% having at least one hospitalization due to HF causing, 16% of all-cause admissions, and 50% of cardiovascular admissions. Male gender, age >90 years, high Charlson Comorbidity Index, atrial fibrillation, present neurologic disease, severe renal impairment, peripheral vascular disease, New York Heart Association class IV, mild or moderate mean aortic valve gradients, and pulmonary hypertension were associated with an increased risk for all-cause hospitalizations or death. For cardiovascular hospitalization or death, the pattern was similar, with the addition of impaired systolic left ventricular function as a predictor.

Conclusion: Multiple hospitalizations after TAVI are common and are often caused by HF. Reducing the rate of HF hospitalizations is important to mitigate the burden on the healthcare system due to new hospitalizations after TAVI.

Citing Articles

Cost-effectiveness analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at low risk of surgical mortality in Sweden.

Nilsson K, James S, Angeras O, Backes J, Bjursten H, Candolfi P Ups J Med Sci. 2024; 129.

PMID: 39691778 PMC: 11650470. DOI: 10.48101/ujms.v129.10741.


Marital status, educational level, and mid-term mortality risk in 5924 patients after transcatheter aortic valve implantation.

Lachonius M, Giang K, Petursson P, Angeras O, Skoglund K, Jeppsson A Eur Heart J Open. 2024; 4(5):oeae077.

PMID: 39364425 PMC: 11448338. DOI: 10.1093/ehjopen/oeae077.


Regional assessment of availability for transcatheter aortic valve implantation in Sweden: a long-term observational study.

Nilsson K, Lindholm D, Backes J, Bjursten H, Hagstrom H, Lindback J Eur Heart J Qual Care Clin Outcomes. 2023; 10(7):641-649.

PMID: 38158216 PMC: 11537233. DOI: 10.1093/ehjqcco/qcad076.


Incidence and Risk Factors for Long-Term Persistence of Diastolic Dysfunction after Aortic Valve Replacement for Aortic Stenosis Compared with Aortic Regurgitation.

Iliuta L, Andronesi A, Scafa-Udriste A, Radulescu B, Moldovan H, Furtunescu F J Cardiovasc Dev Dis. 2023; 10(3).

PMID: 36975895 PMC: 10052670. DOI: 10.3390/jcdd10030131.


Patients' motivation to undergo transcatheter aortic valve replacement. A phenomenological hermeneutic study.

Lachonius M, Wallstrom S, Odell A, Petursson P, Jeppsson A, Skoglund K Int J Older People Nurs. 2022; 18(1):e12521.

PMID: 36464490 PMC: 10078399. DOI: 10.1111/opn.12521.


References
1.
Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

2.
Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

3.
Tarantini G, Mojoli M, Urena M, Vahanian A . Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J. 2016; 38(17):1285-1293. DOI: 10.1093/eurheartj/ehw456. View

4.
Kapadia S, Leon M, Makkar R, Tuzcu E, Svensson L, Kodali S . 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2485-91. DOI: 10.1016/S0140-6736(15)60290-2. View

5.
Jernberg T, Attebring M, Hambraeus K, Ivert T, James S, Jeppsson A . The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010; 96(20):1617-21. DOI: 10.1136/hrt.2010.198804. View